Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor

Life Health > Long-Term Care Planning

Nonprofit Promotes New Provider Compensation Approach

X
Your article was successfully shared with the contacts you provided.

Prometheus Group Inc. says it has developed a way to pay doctors and other providers based partly on whether patients receive the right amount and type of care.

Health policy experts formed Prometheus, Newtown, Conn., in an effort to update provider compensation methods.

Prometheus has dubbed its proposed solution the Evidence-Based Case Rates system.

“An ECR is a payment rate that establishes the total amount to be paid to all providers to care for a patient through an entire episode of care according to what the evidence says is the best protocol in clinical practice guidelines,” according to Prometheus organizers.

If a payer uses the ECR system, 10% to 20% of the payment will go into a “performance contingency fund” linked to patient satisfaction, cost efficiency and the outcome of the care.

Some of the ECR payment will depend on the performance of the providers that a provider refers patients to.

Prometheus will start by trying to apply the ECR system in test markets to compensation for preventive care, routine care, joint replacements and treatment of lung cancer, colon cancer, diabetes, high blood pressure, high cholesterol and heart problems.

Michael Pine and Associates Inc., Chicago, and the RAND Corp., Santa Monica, Calif., are partners in the Prometheus development effort, organizers say.


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.